Page 28 - Rna News Today

A small study of a pancreatic cancer vaccine has given researchers hope that it might be possible to treat this notoriously tough cancer.

This study further highlights the potential of mRNA vaccines in cancer treatment.

Landscape Capital Management L.L.C. acquired a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 9,047 shares of the biotechnology company’s stock, valued at approximately $201,000. Several other institutional investors and […]

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) – Chardan Capital dropped their FY2023 EPS estimates for Avidity Biosciences in a report released on Wednesday, May 10th. Chardan Capital analyst K. Nakae now forecasts that the biotechnology company will earn ($2.94) per share for the year, down from their prior forecast of ($2.90). Chardan Capital currently […]

CSEM has supported the Lausanne-based start-up Alithea Genomics in developing a technology capable of processing hundreds of ribonucleic acid (RNA) samples in a single tube, which translates to a significant reduction in reagents and manual effort in the overall workflow.

While mRNA vaccines are designed to last longer in the body than mRNA molecules typically would, they are also tested to ensure they are eliminated from livestock long before milking or slaughter.

With the emergency phase of the COVID-19 pandemic in the rearview mirror, at least for now, we look back on a handful of stories that provided sharp insights at key moments in the pandemic.

Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Rating) gapped up before the market opened on Wednesday . The stock had previously closed at $10.95, but opened at $11.77. Avidity Biosciences shares last traded at $10.99, with a volume of 329,188 shares traded. Wall Street Analysts Forecast Growth A number of equities research analysts recently […]

For a planet to have liquid surface water and be habitable it must not only be the right distance from its star, but also receive the right amount of ultraviolet (UV) rays essential to forming the biochemical building blocks that are the basis of life (ANSA)

Connecticut researchers are using mRNA technology, used in Moderna's COVID-19 vaccine, to fight melanoma.